Veterinary Medicines

BIOSUIS ParvoEry suspension for injection for pigs

Authorised
  • Porcine parvovirus, strain CAPM V198 S-27, Inactivated
  • Erysipelothrix rhusiopathiae, serotype 2, strain 2-64, Inactivated
Download as PDF

Product identification

Medicine name:
BIOSUIS ParvoEry suspension for injection for pigs
Parvoerybac injeksjonsvæske, suspensjon til gris
Active substance:
  • Porcine parvovirus, strain CAPM V198 S-27, Inactivated
  • Erysipelothrix rhusiopathiae, serotype 2, strain 2-64, Inactivated
Target species:
  • Pig (sow)
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Porcine parvovirus, strain CAPM V198 S-27, Inactivated
    4.00
    log2 haemagglutination inhibiting unit(s)
    /
    1.00
    Dose
  • Erysipelothrix rhusiopathiae, serotype 2, strain 2-64, Inactivated
    1.00
    relative potency
    /
    1.00
    Dose
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Pig (sow)
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI09AL01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Norway
Package description:
  • Glass Vial 1 x 10.0 millilitre(s)
  • Glass Vial 10 x 10.0 millilitre(s)
  • Glass Vial 1 x 50.0 millilitre(s)
  • Plastic Vial 1 x 50.0 millilitre(s)
  • Glass Vial 1 x 100.0 millilitre(s)
  • Plastic Vial 1 x 100.0 millilitre(s)
  • Plastic Vial 1 x 250.0 millilitre(s)

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Bioveta a.s.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Bioveta a.s.
Responsible authority:
  • Norwegian Medical Products Agency
Authorisation number:
  • 21-13867
Date of authorisation status change:
Reference member state:
  • Czechia
Procedure number:
  • CZ/V/0148/001
Concerned member states:
  • Belgium
  • Bulgaria
  • Croatia
  • Denmark
  • Estonia
  • Germany
  • Greece
  • Hungary
  • Ireland
  • Latvia
  • Lithuania
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Norwegian (PDF)
Published on: 4/12/2025
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Norwegian (PDF)
Published on: 4/12/2025
Download